Champions Oncology Inc 最大收入來源為 Pharmacology Services,在最近的收益報告中收入為 48,585,000。就地區而言,United States 是 Champions Oncology Inc 的主要市場,收入為 56,944,000。
Champions Oncology Inc 是否盈利?
無,根據最新的財務報表,Champions Oncology Inc 的淨損失為 $0
Champions Oncology Inc 有負債嗎?
無,Champions Oncology Inc 的負債為 0
Champions Oncology Inc 的流通股有多少?
Champions Oncology Inc 的總流通股為 0
關鍵數據
前收市價
$5.09
開盤價
$5.23
當日範圍
$4.92 - $5.23
52週區間
$4.94 - $8.74
交易量
9.9K
平均成交量
8.6K
股息收益率
--
每股盈餘 (TTM)
-0.17
市值
$68.6M
什麼是 CSBR?
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions (TOS). This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.